Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

2.060 -0.100 (-4.63%)
Streaming Delayed Price Updated: 10:45 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,042
Open 2.140
Bid (Size) 2.050 (300)
Ask (Size) 2.070 (400)
Prev. Close 2.160
Today's Range 2.055 - 2.190
52wk Range 0.6200 - 2.540
Shares Outstanding 124,094,390
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
From Nautilus Biotechnology Inc.
Via GlobeNewswire

Performance

YTD
+7.9%
+7.9%
1 Month
+3.5%
+3.5%
3 Month
+24.1%
+24.1%
6 Month
+186.0%
+186.0%
1 Year
+21.2%
+21.2%

More News

Read More
News headline image
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For October 28, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
Via Benzinga
News headline image
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For April 29, 2025 ↗
Via Benzinga
News headline image
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
What's going on in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?
Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?
Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?
The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market
What is the current price of Nautilus Biotechnology, Inc. - Common Stock?
The current price of Nautilus Biotechnology, Inc. - Common Stock is 2.060
When was Nautilus Biotechnology, Inc. - Common Stock last traded?
The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 02/10/26 10:45 AM ET
What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?
The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 255.63M
How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?
Nautilus Biotechnology, Inc. - Common Stock has 256M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.